Our Partners

Free Content

Week in Review

In My Opinion

Education Center

Podcast Audio

XPRN Press Releases

SFDA What's New

Subscriber Content

News & Analysis

Featured Companies

Industry Insights

Deals & Financings

Trials & Approvals

Gov't & Regulatory

Legal & IP Issues

Stock Watch

Week in Review

Archived Articles

Special Features

Premium Content

Professional Content

ChinaBio® Forums

RSS Feeds

Feedburner

Native XML

Audio XML

>> More feeds...

You are here: Home » About Us » Our Partners

ChinaBio® Today and the ChinaBio® Accelerator are proud to have the following companies and organizations as our partners. These organizations support our efforts to help mentor, fund and connect early stage China biotech companies with U.S. investors and support organizations.

To learn more about out partners, please click on the logos or links below, or contact us directly for an introduction.

Annual Sponsor

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past four decades, Wilson Sonsini Goodrich & Rosati has established its reputation by having an unmatched knowledge of its clients' industries and deep and long-standing contacts throughout the technology sector. www.wsgr.com

Roche is a leading healthcare company with a broad spectrum of innovative medical solutions. For more than 100 years, we have been active in the discovery and development, manufacturing and marketing of novel healthcare solutions. Our products and services bring significant benefit to patients from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. www.roche.com

Unitalen is the largest law firm in China focused exclusively on intellectual property (IP) - patents, trademarks and copyrights - with 26 offices throughout China, including Beijing and Shanghai, and over 500 attorneys. Unitalen's Life Science Practice, headquartered in Beijing, can help emerging China biotechs and U.S. companies secure the IP necessary for success. Their professional staff includes many PhDs educated in China and the U.S. www.unitalenlaw.com/english.htm

Perkins Coie is a leading international law firm offering a full spectrum of legal services. With more than 650 lawyers in 14 offices across the United States and in China, the firm serves great companies ranging in size from start-ups to FORTUNE 100. Many of the firm's clients are leaders in traditional industries and emerging technology markets. www.perkinscoie.com

As the "Entrepreneurs Behind the Entrepreneurs", Sequoia Capital has had the privilege of being the first venture capital investor and business partner in companies that make-up 10% of the NASDAQ's value. Our future depends on the present. The way we ensure a rich supply of fresh investments is to make sure that the founders and management of the companies with which we are currently involved are happy with our performance. www.sequoiacap.com/china/venture-capital

Fenwick & West is a global law firm that provides comprehensive legal services to biotech, medical device, health care and other technology clients of national and international prominence in China and around the world. We have over 275 attorneys with headquarters in the Silicon Valley, California. Our Life Sciences Practice Group is committed to providing strategic, cost-effective and practical legal services in company formation, financings, M&A, patent and other intellectual property matters. We differentiate ourselves by having a deeper understanding of our clients' technologies, industry environments and business needs than is typically expected of lawyers. Another differentiator is our Venture Capital Services Group which helps our clients raise funds from both venture capital funds and angel groups in China and around the world. www.fenwick.com

Mingly China Growth Fund is a private equity fund formed in 2006 to make critical growth and expansion stage investments in China. The Fund Management Team and its Advisors include a collaboration of successful and experienced U.S. and Chinese investment professionals Demonstrated ability to identify sector leaders early and get closely engaged with founders Deep and growing pipeline with active processes to monitor companies, Hands-on operating experience to help transform companies, Global network of contacts to assist with technology, sales and marketing and management expertise, and Both Foreign Currency Fund and RMB Fund to meet the funding needs of various companies. www.mcgf.com.cn

Shanghai Biochip offer a full spectrum of biological discovery resources and expertise to meet the needs of the global pharmaceutical and biotech industries. Shanghai Biochip's broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. Shanghai Biochip invite you to learn more about SBC Services and our team of internationally respected scientists. Determine for yourself the positive impact that collaborating with SBC Services can have on the success of your drug development program. www.shbiochip.com/en/Home.htm

Supporting Partners

Suzhou Industrial Park (SIP) Bio Bay is located in the southwest of SIP Dushu lake high education town. Suzhou Industrial Park, the biggest cooperation program between China and Singapore, is committed to develop into a high-tech industrial park with international competitiveness and a modern, international garden-like township. SIP Bio Bay plays a key role as the innovation base for Suzhou Industrial Park to cultivate biotechnology industry and also an innovation platform for the booming of biotechnology and nanotechnology development of both Suzhou city and China. www.biobay.com.cn/en/index.html

The Bio-pharmaceutical Association of Pudong New Area (BPA), officially founded on September 12, 2002, is serving as a social group registered in Pudong New Area. According to “The Registration And Management Principal For Social Groups”, it will recruit voluntary members from enterprises, research institutes, colleges of medicine and individuals who works in bio-pharmaceutical industry. It is also the registered legal entity approved by the Bureau of Civil Administration of Pudong New Area. Its superior management unit is the Scientific and Technological Association of Pudong New Area. www.pdbpa.cn/about/index-en.htm

Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing government, and part of the Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996, BPBC serves as the focal point for advice on the Beijing government's policy and support programs, and the international bridge between Chinese biotech and pharmaceutical companies with the rest of the world. ChinaBio? Accelerator recently signed a collaboration agreement with BPBC at a press conference held in conjunction with the 11th Annual Healthcare Industry Forum held in Beijing. www.newlife.org.cn/en

The Shanghai Pharma Engine has been largely responsible for the launch of the early stage biotech industry in Shanghai. They operate an incubator in the Zhangjiang Hi-Tech Park located next to ChinaBio's offices with 45 biotech startups housed in two buildings, and they are adding facilities for an additional 100 companies in the next year. The ChinaBio? Accelerator recently signed a collaboration agreement with the Pharma Engine where ChinaBio? will identify co-investment opportunities in the Park and Pudong New Area. www.pharma-engine.com/EN/

Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is a 501(C) (3) nonprofit organization founded in early 2002 by professionals and scholars from local Chinese community in San Diego. We invite all scholars, students and professionals with any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry to join us as members of SABPA. www.sabpa.org/web/index.php

Chinese-American BioPharmaceutical Society (CABS) is a not-for-profit, non-political, non-religious professional organization headquartered in San Francisco, California. With the rapid development of bio/pharmaceutical industry in China, more and more people, regardless of their ethnic backgrounds, are looking toward China for business and scientific opportunities. Recognizing this trend, CABS was established not only to educate the public with the progress in biotech and pharmaceutical fields, but also to serve the Bio/Pharmaceutical professionals who are either with Chinese heritage or with professional interests in China. The majority of CABS members are Chinese scientists, entrepreneurs and students/postdocs in biomedical sciences, working in San Francisco Bay Area bio/pharmaceutical industries, universities, and research institutes. The CABS membership is open to the public. www.cabsweb.org/CABSweb/home_page.jsp

BayHelix is an organization of leaders of Chinese origin in the global life sciences and healthcare community. We aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience. BayHelix is a non-profit organization and its membership is by-invitation-only. www.bayhelix.org

BIOCOM is a leading biotechnology industry association with over 550 leading life science companies from Southern California as members. BIOCOM's initiatives focus on capital formation, public policy, resource development and scientific discovery and development. They have recently launched a special program to educate and connect U.S.-based life science companies with low cost resources and services available in China. www.biocom.org

ChinaBio Accelerator is an non-profit organization created to accelerate the globalization of China's biotechnology industry by providing funding, mentoring and connecting early stage China life science companies to investors and partners in the U.S. ChinaBio's objectives are to assist China's early stage companies by: Increasing the probability of success by mentoring and assisting China entrepreneurs; Providing early stage funding to China life science companies; Expanding business partnership and sales development opportunities; and Expanding professional networks through introductions to investors, partners, customers and media. chinabioex.sites.subhub.com

Media Partners

GB focuses exclusively on the pharmaceutical, healthcare, and biotechnology industries in China. With an understanding of ongoing policy shifts, a global perspective, and a granular knowledge of China’s players and practices, GB maintains a substantial advantage over diversified consulting firms. www.generalbiologic.com

nterfax Group provides news and other information products that are essential for decision-makers in politics and business. Since early 1990s, Interfax has been the main provider of up-to-date news from Russia and countries of the former Soviet Union. We are the most frequently quoted source of information on the region. Over the past few years, Interfax has also become a leading provider of political and business news from China and emerging markets of Central Europe. www.interfax.cn

ChinaBio Today - a new publication covering the China biotech industry. China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology. ChinaBio Today focuses exclusively on the rapidly evolving biotech industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market. . www.chinabiotoday.com